Media
The latest news, announcements and media resources
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Key information
Press releases
- U.S. FDA accepts GSK’s sNDA application for Zejula (niraparib) for first-line maintenance treatment for women with platinum-responsive advanced ovarian cancer
- Our contribution to the fight against novel coronavirus (COVID-19)
- FDA approves GSK’s Voltaren Arthritis Pain for over-the-counter use in the United States
GSK US Twitter
-
GSKUS @GSKUS
#NEWS The @US_FDA has accepted our application for an expanded indication in #ovariancancer. Read more: gsk.to/2TasSqP
about 6 hours ago -
GSKUS @GSKUS
Nishtha is a Product Innovation #Engineer. She creates innovative #nextgen digital products that solve #tech challenges across our #vaccines business to improve R&D and commercial processes, raise margins & optimize #customerexperience. 📐⚙️🧪#EngineeringWeeke#eWeeke#STEMTfdB
about 3 days ago
-
GSK in the US
GSK is dedicated to helping grow the US economy and supporting communities by creating high-quality jobs in areas like R&D, manufacturing, and sales.
-
Pharmaceuticals
Our Pharmaceuticals business is made up of innovative and established medicines and holds leading market positions in respiratory disease and HIV.
-
Vaccines
Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. We deliver over two million vaccine doses per day to people living in over 160 countries.
-
Consumer Healthcare
Our Consumer Healthcare business develops and markets consumer preferred and expert recommended brands in the Oral health, Pain relief, Respiratory, Nutrition/gastro-intestinal and Skin health categories.
